These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32647807)

  • 21. Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial.
    Ibrahim D; Dulipsingh L; Zapatka L; Eadie R; Crowell R; Williams K; Wakefield DB; Cook L; Puff J; Hussain SA
    Infect Dis Ther; 2020 Dec; 9(4):913-926. PubMed ID: 32951151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current views on the potentials of convalescent plasma therapy (CPT) as Coronavirus disease 2019 (COVID-19) treatment: A systematic review and meta-analysis based on recent studies and previous respiratory pandemics.
    Aviani JK; Halim D; Soeroto AY; Achmad TH; Djuwantono T
    Rev Med Virol; 2021 Nov; 31(6):e2225. PubMed ID: 33621405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory consideration on preparation and clinical use of COVID-19 convalescent plasma.
    Yılmaz S; Ertuğrul Örüç N; Özcebe Oİ; Azap A; Çetin AT; Yenicesu İ; Öztürk A; Gündüz M; Tekin A
    Transfus Apher Sci; 2020 Oct; 59(5):102846. PubMed ID: 32593519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.
    Li L; Zhang W; Hu Y; Tong X; Zheng S; Yang J; Kong Y; Ren L; Wei Q; Mei H; Hu C; Tao C; Yang R; Wang J; Yu Y; Guo Y; Wu X; Xu Z; Zeng L; Xiong N; Chen L; Wang J; Man N; Liu Y; Xu H; Deng E; Zhang X; Li C; Wang C; Su S; Zhang L; Wang J; Wu Y; Liu Z
    JAMA; 2020 Aug; 324(5):460-470. PubMed ID: 32492084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early safety indicators of COVID-19 convalescent plasma in 5000 patients.
    Joyner MJ; Wright RS; Fairweather D; Senefeld JW; Bruno KA; Klassen SA; Carter RE; Klompas AM; Wiggins CC; Shepherd JR; Rea RF; Whelan ER; Clayburn AJ; Spiegel MR; Johnson PW; Lesser ER; Baker SE; Larson KF; Ripoll JG; Andersen KJ; Hodge DO; Kunze KL; Buras MR; Vogt MN; Herasevich V; Dennis JJ; Regimbal RJ; Bauer PR; Blair JE; Van Buskirk CM; Winters JL; Stubbs JR; Paneth NS; Verdun NC; Marks P; Casadevall A
    J Clin Invest; 2020 Sep; 130(9):4791-4797. PubMed ID: 32525844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals.
    Beaudoin-Bussières G; Laumaea A; Anand SP; Prévost J; Gasser R; Goyette G; Medjahed H; Perreault J; Tremblay T; Lewin A; Gokool L; Morrisseau C; Bégin P; Tremblay C; Martel-Laferrière V; Kaufmann DE; Richard J; Bazin R; Finzi A
    mBio; 2020 Oct; 11(5):. PubMed ID: 33067385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of convalescent plasma to treat emerging infectious diseases: focus on Ebola virus disease.
    Winkler AM; Koepsell SA
    Curr Opin Hematol; 2015 Nov; 22(6):521-6. PubMed ID: 26457963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of COVID-19 Patients with Convalescent Plasma in Houston, Texas.
    Salazar E; Perez KK; Ashraf M; Chen J; Castillo B; Christensen PA; Eubank T; Bernard DW; Eagar TN; Long SW; Subedi S; Olsen RJ; Leveque C; Schwartz MR; Dey M; Chavez-East C; Rogers J; Shehabeldin A; Joseph D; Williams G; Thomas K; Masud F; Talley C; Dlouhy KG; Lopez BV; Hampton C; Lavinder J; Gollihar JD; Maranhao AC; Ippolito GC; Saavedra MO; Cantu CC; Yerramilli P; Pruitt L; Musser JM
    medRxiv; 2020 May; ():. PubMed ID: 32511574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma.
    Salazar E; Perez KK; Ashraf M; Chen J; Castillo B; Christensen PA; Eubank T; Bernard DW; Eagar TN; Long SW; Subedi S; Olsen RJ; Leveque C; Schwartz MR; Dey M; Chavez-East C; Rogers J; Shehabeldin A; Joseph D; Williams G; Thomas K; Masud F; Talley C; Dlouhy KG; Lopez BV; Hampton C; Lavinder J; Gollihar JD; Maranhao AC; Ippolito GC; Saavedra MO; Cantu CC; Yerramilli P; Pruitt L; Musser JM
    Am J Pathol; 2020 Aug; 190(8):1680-1690. PubMed ID: 32473109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment for emerging viruses: Convalescent plasma and COVID-19.
    Brown BL; McCullough J
    Transfus Apher Sci; 2020 Jun; 59(3):102790. PubMed ID: 32345485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Convalescent Blood: Current Perspective on the Efficacy of a Legacy Approach in COVID-19 Treatment.
    Sheervalilou R; Shirvaliloo M; Sargazi S; Bahari S; Saravani R; Shahraki J; Shirvalilou S; Shahraki O; Nazarlou Z; Shams Z; Ghaznavi H
    Blood Purif; 2022; 51(1):1-14. PubMed ID: 33789273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 Infection of Rhesus Macaques Treated Early with Human COVID-19 Convalescent Plasma.
    Deere JD; Carroll TD; Dutra J; Fritts L; Sammak RL; Yee JL; Olstad KJ; Reader JR; Kistler A; Kamm J; Di Germanio C; Shaan Lakshmanappa Y; Elizaldi SR; Roh JW; Simmons G; Watanabe J; Pollard RE; Usachenko J; Immareddy R; Schmidt BA; O'Connor SL; DeRisi J; Busch MP; Iyer SS; Van Rompay KKA; Hartigan-O'Connor DJ; Miller CJ
    Microbiol Spectr; 2021 Dec; 9(3):e0139721. PubMed ID: 34817208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Convalescent plasma appears efficacious and safe in COVID-19.
    Khulood D; Adil MS; Sultana R; Nimra
    Ther Adv Infect Dis; 2020; 7():2049936120957931. PubMed ID: 33062267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis.
    Senefeld JW; Franchini M; Mengoli C; Cruciani M; Zani M; Gorman EK; Focosi D; Casadevall A; Joyner MJ
    JAMA Netw Open; 2023 Jan; 6(1):e2250647. PubMed ID: 36633846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT).
    Tomita N; Saito S; Terada-Hirashima J; Mikami A; Uemura Y; Kutsuna S; Nomoto H; Fujisawa K; Nagashima M; Terada M; Ashida S; Morioka S; Satake M; Hangaishi A; Togano T; Shiratori K; Takamatsu Y; Maeda K; Ohmagari N; Sugiura W; Mitsuya H
    Life (Basel); 2022 Jun; 12(6):. PubMed ID: 35743887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Convalescent plasma therapy in patients with severe COVID-19, A single-arm, retrospective study.
    Ghadami L; Hasibi M; Asadollahi-Amin A; Asanjarani B; Farahmand M; Abdollahi H
    Microb Pathog; 2022 Apr; 165():105482. PubMed ID: 35288278
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.